FDA awards $6.6M grant to pediatric group for work with medical devices

A pediatric group has been awarded a multi-million dollar grant to continue its effort to promote the development and clinical use of pediatric medical devices.

The West Coast Consortium for Technology and Innovation in Pediatrics (CTIP) was recently awarded a five-year, $6.6 million grant by the FDA. According to a press release, the organization promotes the commercialization and clinical use of pediatric medical device technology and is based at the Children’s Hospital Los Angeles and University of Southern California.

“The group fosters networking opportunities, direct and indirect financial support and guidance on issues related to intellectual property, prototyping, engineering, testing, grant writing and clinical trial design—all on the road to getting the devices to market,” the release stated.

The grant will allow the organization to continue its work to improve “child health outcomes by advancing pediatric medical devices.”

“Our mission is to improve health outcomes for our vulnerable pediatric population,” Juan Espinoza, MD, general pediatrician at Children’s Hospital Los Angeles and co-director of CTIP, said in a statement. “To be recognized by the FDA as a center of excellence for pediatric innovation and to serve as a national resource for pediatric device development is both a  great honor and great responsibility. We feel fortunate to be working with some of the finest institutions on the West Coast to support and foster collaboration in medical technology development.”

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”